Abstract:Abstract Background Immune cells in the tumor microenvironment play an important role in cancer development [1]. In triple negative breast cancer (TNBC), stromal tumor-infiltrating lymphocytes (sTILs) have been identified as a biomarker with both predictive and prognostic clinical values [2]. The High Throughput Truthing project collected sTILs density estimates in hematoxylin and eosin stained invasive breast cancer biopsy specimens. The goal of the project is to produce a dataset to validate artificial intelligence and machine learning models [3]. After collecting annotations from pathologists for a pilot study, we observed a high level of interobserver variability in sTILs density estimates. To improve pathologist accuracy in breast cancer sTILs assessment, we created educational materials using an expert panel and pilot study data. Method The pilot study data consisted of 640 unique regions of interest (ROIs) derived from 64 digital whole slide images. We categorized ROIs based on their mean sTILs density as “10% or less”, “11% to 40%”, or “greater than 40%”, and selected 72 unique ROIs from those with the highest and lowest pathologist variability in each density bin. In a series of eight one-hour sessions, each ROI was reviewed in a group setting by at least three members of our expert panel, which consisted of one clinical scientist and seven board-certified pathologists trained in breast cancer sTILs assessment. Experts provided estimates of the percent of tumor-associated stroma and sTILs density, and commentary on features that confound sTILs assessment for each ROI. Results We created a set of educational materials to teach the sTILs assessment methodology in breast cancer. These materials include an introduction to the clinical relevance of tumor infiltrating lymphocytes in the breast cancer microenvironment, a tutorial for assessing sTILs according to published guidelines [4], and a discussion of specific pitfalls that may be encountered. Expert panel annotations, comments, and pitfalls were used to generate a reference document and interactive tests: one with expert feedback on each ROI and one to determine proficiency. Conclusions Educational materials designed by an expert panel will serve as reference materials for learning sTILs assessment in breast cancer. Our work provides valuable education for pathologists, and directly supports their ability to provide up-to-date diagnostic information used in caring for breast cancer patients. References: 1. Zitvogel, L., Tesniere, A. & Kroemer, G. Cancer despite immunosurveillance: immunoselection and immunosubversion | Nature Reviews Immunology. https://www.nature.com/articles/nri1936. 2. Loi, S. et al. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers. J Clin Oncol 37, 559–569 (2019). 3. Dudgeon, S. N. et al. A pathologist-annotated dataset for validating artificial intelligence: A project description and pilot study. Journal of Pathology Informatics 12, 45 (2021). 4. Salgado, R. et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Annals of Oncology 26, 259–271 (2015). Citation Format: Victor Garcia, Amy Ly, Roberto Salgado, Brandon D. Gallas. Educating pathologists in quantitating stromal tumor-infiltrating lymphocytes in breast cancer for artificial intelligence applications [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P1-08-05.

Utility of Indigenously Developed Square Grid Method for Evaluation of Tumor-Stroma Ratio and Stromal Tumor-Infiltrating Lymphocytes in Invasive Breast Carcinoma: A Pilot Study

Abstract P1-08-05: Educating pathologists in quantitating stromal tumor-infiltrating lymphocytes in breast cancer for artificial intelligence applications

Study of Tumor-Infiltrating Lymphocytes in Breast Carcinoma and Their Association With Pathological and Prognostic Factors and Pathological Tumor-Node-Metastasis (pTNM) Staging

Clinico-pathological co-relation using various immuno-histochemistry markers likeER, PR, HER-2 NEU, CK5/6, EGFR, KI-67 in carcinoma breast

Assessment of stromal tumor-infiltrating lymphocytes in neoadjuvant chemotherapy for invasive breast carcinoma: Predictive insights across molecular subtypes

Automated scoring methods for quantitative interpretation of Tumour infiltrating lymphocytes (TILs) in breast cancer: a systematic review

Gross Evaluation of Breast Carcinomas Post-Neoadjuvant Chemotherapy Without Radio-opaque Clip Insertion

Significance of tumor-infiltrating lymphocytes in tumor regression in breast cancer: A study in a tertiary care cancer center in South India

Correlation between Thyroid Imaging Reporting and Data System and Bethesda System of Reporting of Thyroid Cytopathology of Thyroid Nodule: A Single Center Experience

Gross Evaluation of Breast Carcinomas Post–Neoadjuvant Chemotherapy Without Radio-opaque Clip Insertion

Assessing the use of the triglyceride-glycemic index (TyG), neutrophil-lymphocyte Ratio (NLR), and platelet-lymphocyte Ratio (PLR) in distinguishing benign and malignant tumors among patients with complaints of breast mass

Comparison of Intraoperative Imprint Cytology versus Frozen Section for Sentinel Lymph Node Evaluation in Breast Cancer. A study along with Systematic Review and Meta-analysis of literature

Correlation of tumor budding with a novel and other established prognostic parameters in patients with invasive breast carcinoma

Correlation Of Bi-Rads 4 Subcategories Breast Lesions On Tomosynthesis And Histopathological Examination With P63 Immunohistochemistry Expression

Image analysis for bright-field HER2 in situ hybridization: validation for clinical use

Computerized Assessment of the Tumor-stromal Ratio and Proposal of a Novel Nomogram for Predicting Survival in Invasive Breast Cancer

Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes

Exploring the Usefulness of Tumor Budding as a Histopathological Marker Compared to Tumor-Node-Metastasis (TNM) Staging in Breast Cancer

Evaluation of the mitotic score of invasive breast carcinomas on digital slide: development and contribution of a mitosis detection algorithm

Efficacy of intraoperative imprint cytology of sentinel lymph node in breast cancer

International Academy of Cytology standardized reporting of breast fine-needle aspiration cytology with cyto-histopathological correlation of breast carcinoma